Delivery Order SPE2DB24D2213-SPE2DB25FGWHW

Award Date 4/3/25
Potential Completion Date 4/4/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,507.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,561,119,982 units of Cefdinir 300 mg capsules in quantities of 60s. This is a firm fixed-price delivery order contract, with a completion date of June 5, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,758.90 firm-fixed-price delivery order is for the supply of 4,558,375,952 units of the medication Cefdinir 300 mg capsules. The award has an ultimate completion date of September 9, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
This federal contract award, valued at $1,220.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,358,140 units of the medication Cefdinir 300 mg capsules, with a completion date of January 19, 2024. The contract is a Delivery Order under a Firm Fixed Price contract type. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,414.40, is for the delivery of 4562594711 - CEFDINIR 300 MG CAPSULE 60S. It is a Firm Fixed Price Delivery Order contract, with an ultimate completion date of October 26, 2023. The contract is not designated with any set-aside requirements, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,348.56, is for the delivery of 4564603625 CEFDINIR 300 MG CAPSULE 60S, a generic pharmaceutical product. The contract type is Delivery Order with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of May 15, 2024. This award is not designated as a set-aside...
This is a $1,633.36 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CEFDINIR 300 MG CAPSULE 60S, a pharmaceutical product, with a performance period through May 13, 2025. This delivery order is not set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA...
This federal contract award, identified as SPE2DB20D2002|SPE2DB25FL40X, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,935.60 firm fixed-price delivery order is for the procurement of 4,568,152,967 units of the medication CEFDINIR 300 MG CAPSULE 60S. The contract has an ultimate completion date of May 7, 2025 and was awarded on May 6, 2025. This delivery order is...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Cefdinir 250 mg/5 ml suspension (60 ml) to the Defense Logistics Agency (DLA). The ceiling value of the delivery order is $1,380.00, and the ultimate completion date is April 17, 2024. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) awarded without a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger single-award...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,732.47, is a delivery order for the pharmaceutical product CEFDINIR 250 MG/5 ML SUSP 60ML. The contract has an ultimate completion date of November 18, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of the pharmaceutical drug Cefdinir 250 mg/5 ml suspension in 100 ml bottles. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $1,257.66, is a Firm Fixed Price delivery order placed under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued...
  • SPE2DB24D2213
    Indefinite Delivery Contract
  • SPE2DB24D2213-SPE2DB25FGWHW
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,591.67 firm fixed-price delivery order is for the supply of 4,567,792 capsules of the drug Cefdinir 300 mg. The contract has an ultimate completion date of April 4, 2025.

This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 7/3/25, 3:00 PM